Dopamine beta-hydroxylase. Inactivation by a suicide substrate. 1980

J M Baldoni, and J J Villafranca

Dopamine beta-hydroxylase (EC 1.14.17.1) is inactivated by p-hydroxybenzylcyanide (PHBC) in a manner characteristic of a suicide substrate. The inactivation 1) is first order in inhibitor (Kd = 1.9 mM, k2 = 0.05 min-1, pH 5.0), 2) exhibits saturation kinetics, and 3) is dependent on O2 and ascorbate. Restoration of activity could not be achieved by dialysis. The substrate, p-tyramine, protects the enzyme from inactivation, while in initial velocity kinetic experiments, PHBC is a linear competitive inhibitor (Kis = 2.6 mM) versus p-tyramine. The Kis value for PHBC is in good agreement with the Kd value obtained from analysis of the inactivation reaction. PHBC (in the presence of O2 and ascorbate) is also a substrate for the enzyme, being converted to p-hydroxymandelonitrile (PHMN) at a relative Vmax 13% that of p-tyramine. Under these conditions, the ratio of product formation to inactivation is 8000:1, suggesting that PHMN (or a tautomer of PHMN) is the species responsible for inactivation. Indeed, incubation of the enzyme with PHMN in the absence of ascorbate leads to irreversible inactivation. Since PHMN breaks down to p-hydroxybenzaldehyde and cyanide, experiments were conducted to determine whether these compounds may have been responsible for the inactivation. Incubation of the enzyme with p-hydroxybenzaldehyde did not lead to inactivation, whereas the inactivation produced with cyanide could be reversed by dialysis. Thus, the data point to PHMN as the molecule responsible for time-dependent loss of activity of the enzyme. Together, these experiments demonstrate that the newly discovered inhibitor, PHBC, meets the critieria for a suicide substrate for dopamine beta-hydroxylase.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011190 Potassium Cyanide A highly poisonous compound that is an inhibitor of many metabolic processes, but has been shown to be an especially potent inhibitor of heme enzymes and hemeproteins. It is used in many industrial processes. Potassium Cyanide (K(14)CN),Potassium Cyanide (K(C(15)N)),Cyanide, Potassium
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002837 Chromaffin Granules Organelles in CHROMAFFIN CELLS located in the adrenal glands and various other organs. These granules are the site of the synthesis, storage, metabolism, and secretion of EPINEPHRINE and NOREPINEPHRINE. Chromaffin Granule,Granule, Chromaffin
D004299 Dopamine beta-Hydroxylase Dopamine beta-Monooxygenase,Dopamine beta Hydroxylase,Dopamine beta Monooxygenase,beta-Hydroxylase, Dopamine,beta-Monooxygenase, Dopamine
D000097 Acetonitriles Compounds in which a methyl group is attached to the cyano moiety. Cyanomethane,Cyanomethanes,Ethane Nitriles,Methyl Cyanide,Methyl Cyanides,Cyanide, Methyl,Cyanides, Methyl,Nitriles, Ethane
D000313 Adrenal Medulla The inner portion of the adrenal gland. Derived from ECTODERM, adrenal medulla consists mainly of CHROMAFFIN CELLS that produces and stores a number of NEUROTRANSMITTERS, mainly adrenaline (EPINEPHRINE) and NOREPINEPHRINE. The activity of the adrenal medulla is regulated by the SYMPATHETIC NERVOUS SYSTEM. Adrenal Medullas,Medulla, Adrenal,Medullas, Adrenal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

J M Baldoni, and J J Villafranca
April 1986, The Journal of biological chemistry,
J M Baldoni, and J J Villafranca
December 1993, Carbohydrate research,
J M Baldoni, and J J Villafranca
February 2001, FEBS letters,
J M Baldoni, and J J Villafranca
January 1983, Biochemical and biophysical research communications,
J M Baldoni, and J J Villafranca
January 1974, Journal of psychiatric research,
J M Baldoni, and J J Villafranca
January 1980, Essays in neurochemistry and neuropharmacology,
J M Baldoni, and J J Villafranca
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
J M Baldoni, and J J Villafranca
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
J M Baldoni, and J J Villafranca
June 1965, Pharmacological reviews,
Copied contents to your clipboard!